Blood Component Separator NGL XFC 3000 Apheresis Machine

Share on (1601081350896):


Price:

Quantity:


Product Overview

Description



Product Description




Overview

Fully Automatic Blood Centrifuge Platelet Collection TPE therapeutic plasma exchange machine

The blood component separator applies many advanced core technologies such as computer, multi-field sensory technology, anti-contamination peristaltic pumping when transporting liquid, and blood centrifugal separation, to complete multi-component collection for therapeutic use.

1. In time, the alarm is an abnormality and displays the prompt message, keep working after the handling.

2. A self-continued, automatic, continuous-flow, centrifugal device that separates whole blood into various leukoreduced components.

3. Comprehensive error and diagnostic messages

4. Easy-to-read display

5. Leakage detector inside the centrifuge

6. Donor-dependent return flow rates for optimal donor comfort.

7. Advanced pipeline detectors and sensors enable the collection of high-quality blood components.

8. Single needle mode, simple operation, and minimal training required

9. A compact design, ideal for mobile collection sites.


Details Images




Specification


Product
Blood Component Separator NGL XCF 3000
Place of Origin
Sichuan, China
Brand
Nigale
Model Number
NGL XCF 3000
Certificate
ISO13485/CE
Instrument Classification
Class III
Warranty
1 Year
Dimension
570*360*440mm
Weight
42KG


Certifications




Company Profile




Nigale is a leading enterprise specializing in the manufacturing of automated blood processing devices and disposable kits. Headquartered in Chengdu, the capital of Sichuan province, historically recognized as the Province of Abundance, Nigale operates its production base in Jianyang, with Beijing serving as the location for its fully-owned subsidiary. Established in 1994, Nigale concentrates on products within the field of transfusion medicine, benefiting from robust technical support from the Institute of Blood Transfusion and Hematology of the Chinese Academy of Medical Sciences, as well as the Sichuan Provincial Academy of Medical Sciences.

In August 2001, Nigale transitioned into a limited liability company and subsequently evolved into a private limited liability
company by March 2004. Today, Nigale has emerged as a national leader in the manufacturing, sales, and service of blood processing systems in China. We have secured over twenty patents, encompassing inventions, utility models, and software. All our products hold Chinese SFDA certificates, ISO13485 certifications, CMDCAS certifications, and CE marks, ensuring compliance with international standards in terms of quality, specification variety, and service.

Nigale's product range is primarily employed in blood cell separation and filtration, plasma exchange therapy, as well as
operating room and clinical therapies within hospital settings.


0.1565 s.